Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest Pharmaceuticals

23 Apr, 2018, 13:00 BST ClinicalStudyDataRequest.com Announces Partnerships with Global Academic Research Funders to Expand Researchers' Access to Patient-level Clinical Trial Data

ClinicalStudyDataRequest.com (CSDR), the first-in-class online resource giving researchers access to patient-level clinical trial data from 14 of...


23 Apr, 2018, 13:00 BST Global Respiratory Syncytial Virus (RSV) Therapeutics Market to Reach US$ 2120.0 Million by 2025, Says TMR

The global respiratory syncytial virus therapeutics market was valued at approximately US$ 820.0 Mn in 2016 is projected to expand at a CAGR of...


23 Apr, 2018, 13:00 BST Merck Receives Patent for CRISPR Technology in China

- Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells - Company to license CRISPR-related...


23 Apr, 2018, 11:41 BST Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)

Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board....


23 Apr, 2018, 07:00 BST Darling Ingredients Inc. Announces Private Offering of €515 Million of Unsecured Senior Notes by Darling Global Finance B.V.

Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect,...


23 Apr, 2018, 07:00 BST Darling Ingredients Inc. Announces Cash Tender Offer By Darling Global Finance B.V. For Any And All 4.75% Senior Notes Due 2022

Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. ("DG Finance"), an indirect,...


23 Apr, 2018, 04:43 BST Juntendo University Research: Malaria in Africa is Developing Resistance to Drugs

Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 million new cases estimated in 2016 alone,...


23 Apr, 2018, 00:01 BST Creation of Inceptua Clinical Trial Services Marks New Era for the Company

Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial...


21 Apr, 2018, 11:00 BST New Data Show That High Quality Cleansing Improves Lesion Detection During Colonoscopy Compared to Adequate Cleansing[i]

Norgine B.V. today announced new data showing that there is a strong correlation between higher cleansing scores and increased polyp detection...


20 Apr, 2018, 15:10 BST Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023

Abbott (NYSE: ABT) and the World Marathon Majors today announced the renewal of Abbott's title sponsorship. The partnership will extend into 2023,...


20 Apr, 2018, 13:57 BST Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem

More than 20 per cent of patients with outpatient urinary tract infections (UTIs) receive an antibiotic to which the responsible pathogen is not...


20 Apr, 2018, 10:42 BST NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that its mitochondrial myopathy project, NVP025, has been...


20 Apr, 2018, 08:02 BST New Research Shows Significant Benefits for COPD Patients in the Home Using Fisher & Paykel Healthcare's myAirvo

Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which...


20 Apr, 2018, 07:57 BST NeuroVive's Board Members, Senior Executives and Employees Will Subscribe Units in the Ongoing Rights Issue

In the current rights issue in NeuroVive, the Board, Senior Executives and employees have undertaken to subscribe for at least 191,200 units...


20 Apr, 2018, 06:00 BST UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen

- Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute...


19 Apr, 2018, 20:13 BST Statement regarding Shire plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...


19 Apr, 2018, 15:05 BST PharmaBoardroom Releases 'Healthcare and Life Sciences Review Baltics 2018'

PharmaBoardroom today releases its new 79-page Healthcare & Life Sciences Review Baltics 2018. While Lithuania, Latvia and Estonia have a lot...


19 Apr, 2018, 15:00 BST Global Nutraceuticals Market to Rise to US$278.96 Bn by 2021; Rising Demand Across Emerging Economies to Help Market Pick Pace

Despite featuring a highly competitive vendor landscape owing to the presence of a large number of companies spread across the globe...


19 Apr, 2018, 14:15 BST Vaccine Sales Market Forecast 2018-2028 - Visiongain Report

Paediatric Vaccines, Adult Vaccines, Elderly Vaccines, Travel Vaccines, Therapeutic Vaccines, Prevnar, Gardasil, Fluzone, Pentacel, ProQuad,...


19 Apr, 2018, 14:00 BST The Tear Film and Ocular Surface Society (TFOS) Recognizes the Bioprotectant Properties of Trehalose, a Component of Thealoz® Duo,* in the Treatment of Dry Eye

The TFOS international Dry Eye WorkShop II (TFOS DEWS II), whose report has been published in the July 2017 issue of the Ocular Surface...


19 Apr, 2018, 10:00 BST OBI Pharma Announces FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors

First clinical trial to test the safety and efficacy of a novel first-in-class targeted therapy (small-molecule prodrug) that selectively releases...


19 Apr, 2018, 09:00 BST Neuropeptide Y Y1 receptor Structures Offer New Opportunities for Anti-obesity Drug Discovery

- Structures of human neuropeptide Y receptor Y1R reveal drug recognition mechanisms Obesity is a major public health concern. Each year,...


19 Apr, 2018, 00:01 BST BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development

BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the...


18 Apr, 2018, 14:30 BST High Potency APIs /HPAPI Market Worth 26.84 Billion USD by 2023

According to a new market research report "High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB,...


18 Apr, 2018, 13:15 BST Cannabis Markets Primed for Robust Growth as Global Spending Projected to Reach $57 Billion

MarketNewsUpdates.com News Commentary The global cannabis industry is in a position to significantly expand and enhance operations as spending...